At the same time, EBNA1 can promote the degradation of Smad2 protein and inhibit the transcription of TGF-β target gene protein tyrosine phosphatase receptor κ (PTPRK), thereby promoting the growth and survival of Hodgkin lymphoma (HL) cells [57]. This evidence concerns the gene PTPRK and Hodgkins lymphoma.